ArticleJournal of cancer research and clinical oncology2025
MRI-based radiomics signatures for predicting the efficacy of targeted therapy with lenvatinib in hepatocellular carcinoma: a retrospective cohort study.
Kun Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.